Clinical trial
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)
NCT00245401 · Cordis US Corp., Industry · Completed
Key facts
| NCT number | NCT00245401 |
|---|---|
| Title | CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) |
| Official title | CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS) |
| Lead sponsor | Cordis US Corp., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Artery Disease |
| Intervention type | Device |
| Interventions | CYPHERTM Sirolimus-Eluting Coronary Stent |
| Enrollment | 2,070 |
| Start date | Aug 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Oct 28, 2005 |
| Last update posted | Apr 4, 2007 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: